A risk-characterization framework for decision-making at the Food and Drug Administration / (Record no. 2943269)

MARC details
000 -LEADER
fixed length control field 08076cam a2201033 i 4500
001 - CONTROL NUMBER
control field ocn741650502
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220713071348.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr un|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 140702s2011 dcua obt 000 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2011283692
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency NLM
Modifying agency N$T
-- NATAP
-- CDX
-- WVH
-- DKDLA
-- ZMC
-- E7B
-- IDEBK
-- DEBSZ
-- YBM
-- OCLCF
-- NLGGC
-- YDXCP
-- EBLCP
-- OCLCO
-- OCLCQ
-- OCLCO
-- LOA
-- OCLCO
-- OCLCA
-- OCLCQ
-- OCLCO
-- AGLDB
-- PIFAG
-- ZCU
-- OCLCQ
-- MERUC
-- U3W
-- OCLCQ
-- OCLCO
-- OCL
-- STF
-- WRM
-- VTS
-- NRAMU
-- EZ9
-- ICG
-- VT2
-- OCLCQ
-- OCLCO
-- MERER
-- WYU
-- LVT
-- TKN
-- U3G
-- DKC
-- OCLCQ
-- UKAHL
-- OCLCQ
-- NLM
-- OCLCO
-- AJS
-- OCLCO
-- OCLCA
-- OCLCO
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 101638901
Source DNLM
019 ## -
-- 742515383
-- 743413565
-- 816844562
-- 923283476
-- 1021265268
-- 1062919609
-- 1081249833
-- 1156389155
-- 1228530382
-- 1229860501
-- 1249216073
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780309212816
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0309212812
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1283135167
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781283135160
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9780309212809
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 0309212804
029 0# - (OCLC)
OCLC library identifier NLM
System control number 101638901
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000051598503
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV043033783
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV044109219
029 1# - (OCLC)
OCLC library identifier DEBSZ
System control number 372699588
029 1# - (OCLC)
OCLC library identifier DEBSZ
System control number 421588497
029 1# - (OCLC)
OCLC library identifier DEBSZ
System control number 452578191
029 1# - (OCLC)
OCLC library identifier GBVCP
System control number 803607997
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)741650502
Canceled/invalid control number (OCoLC)742515383
-- (OCoLC)743413565
-- (OCoLC)816844562
-- (OCoLC)923283476
-- (OCoLC)1021265268
-- (OCoLC)1062919609
-- (OCoLC)1081249833
-- (OCoLC)1156389155
-- (OCoLC)1228530382
-- (OCoLC)1229860501
-- (OCoLC)1249216073
042 ## - AUTHENTICATION CODE
Authentication code pcc
043 ## - GEOGRAPHIC AREA CODE
Geographic area code n-us---
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RA401.A3
Item number R57 2011eb
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number WA 289
072 #7 - SUBJECT CATEGORY CODE
Subject category code POL
Subject category code subdivision 020000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 353.9/970973
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
110 2# - MAIN ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element National Academies (U.S.).
Subordinate unit Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II,
Relator term author.
9 (RLIN) 1514028
245 12 - TITLE STATEMENT
Title A risk-characterization framework for decision-making at the Food and Drug Administration /
Statement of responsibility, etc Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, Board on Environmental Studies and Toxicolgoy, Division on Earth and Life Studies, National Research Council, Institute of Medicine, National Research Council of the National Academies.
264 #1 -
-- Washington D.C. :
-- National Academies Press,
-- [2011]
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (1 PDF file (xiv, 192 pages)) :
Other physical details illustrations
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
500 ## - GENERAL NOTE
General note Title from PDF title page.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references.
520 3# - SUMMARY, ETC.
Summary, etc With the responsibility to ensure the safety of food, drugs, and other products, the U.S. Food and Drug Administration (FDA) faces decisions that may have public-health consequences every day. Often the decisions must be made quickly and on the basis of incomplete information. FDA recognized that collecting and evaluating information on the risks posed by the regulated products in a systematic manner would aid in its decision-making process. Consequently, FDA and the Department of Health and Human Services (DHHS) asked the National Research Council (NRC) to develop a conceptual model that could evaluate products or product categories that FDA regulates and provide information on the potential health consequences associated with them. A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration describes the proposed risk-characterization framework that can be used to evaluate, compare, and communicate the public-health consequences of decisions concerning a wide variety of products. The framework presented in this report is intended to complement other risk-based approaches that are in use and under development at FDA, not replace them. It provides a common language for describing potential public-health consequences of decisions, is designed to have wide applicability among all FDA centers, and draws extensively on the well-vetted risk literature to define the relevant health dimensions for decision-making at the FDA. The report illustrates the use of that framework with several case studies, and provides conclusions and recommendations.
536 ## - FUNDING INFORMATION NOTE
Text of note This project was supported by Contract HHSP23320042509XI/HHSP233200800001T between the National Academy of Sciences and the U.S. Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the organizations or agencies that provided support for this project.
588 0# -
-- Version viewed October 3, 2014.
505 00 - FORMATTED CONTENTS NOTE
Title Introduction --
-- A Risk-Characterization Framework --
-- Case Study of a Mitigation-Selection Decision --
-- Case Study of a Targeting Decision --
-- Case Study of a Strategic-Investment Decision --
-- Case Study of a Targeting Decision That Spans Food and Drug Administration Centers --
-- Conclusions and Future Directions --
Miscellaneous information A:
Title Letter Report on the Development of a Model for Ranking FDA Product Categories on the Basis of Health Risks --
Miscellaneous information B:
Title Statement of Task for the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II --
Miscellaneous information C:
Title Scenarios Provided by the U.S. Food and Drug Administration to the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II --
Miscellaneous information D:
Title Biographic Information on the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II --
Miscellaneous information E:
Title Factors Hypothesized as Important in Understanding Risk.
590 ## - LOCAL NOTE (RLIN)
Local note eBooks on EBSCOhost
Provenance (VM) [OBSOLETE] EBSCO eBook Subscription Academic Collection - Worldwide
610 10 - SUBJECT ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element United States.
Subordinate unit Food and Drug Administration
Form subdivision Case studies.
9 (RLIN) 1514029
610 12 - SUBJECT ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element United States.
Subordinate unit Food and Drug Administration.
9 (RLIN) 9402
610 17 - SUBJECT ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element United States.
Subordinate unit Food and Drug Administration.
Source of heading or term fast
-- (OCoLC)fst00549734
9 (RLIN) 9402
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Decision making
Geographic subdivision United States
Form subdivision Case studies.
9 (RLIN) 307752
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Product safety
Geographic subdivision United States
General subdivision Decision making
Form subdivision Case studies.
9 (RLIN) 1514030
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Risk assessment
Geographic subdivision United States
Form subdivision Case studies.
9 (RLIN) 1514031
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Decision making.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Risk Assessment
General subdivision methods
9 (RLIN) 932252
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Consumer Product Safety
9 (RLIN) 1085921
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Approval
9 (RLIN) 342421
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Decision Making
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element United States Government Agencies
9 (RLIN) 1034190
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Prise de décision
Geographic subdivision États-Unis
Form subdivision Études de cas.
9 (RLIN) 873057
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Produits commerciaux
General subdivision Sécurité
Geographic subdivision États-Unis
General subdivision Prise de décision
Form subdivision Études de cas.
9 (RLIN) 1514032
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Évaluation du risque
Geographic subdivision États-Unis
Form subdivision Études de cas.
9 (RLIN) 1514033
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Prise de décision.
9 (RLIN) 874731
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element decision making.
Source of heading or term aat
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element POLITICAL SCIENCE
General subdivision Government
-- State & Provincial.
Source of heading or term bisacsh
9 (RLIN) 849788
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Decision making.
Source of heading or term fast
-- (OCoLC)fst00889035
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Risk assessment.
Source of heading or term fast
-- (OCoLC)fst01098146
9 (RLIN) 35942
651 #7 - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Geographic name United States.
Source of heading or term fast
-- (OCoLC)fst01204155
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Case studies.
Source of term fast
-- (OCoLC)fst01423765
9 (RLIN) 59979
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
Title Risk-characterization framework for decision-making at the Food and Drug Administration.
Place, publisher, and date of publication Washington, D.C. : National Academies Press, ©2011
International Standard Book Number 9780309212809
Record control number (OCoLC)741786294
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Online access: National Academy of Sciences National Academies Press.
9 (RLIN) 875383
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Online access: NCBI NCBI Bookshelf.
9 (RLIN) 875384
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=372484">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=372484</a>
938 ## -
-- Askews and Holts Library Services
-- ASKH
-- AH36617393
938 ## -
-- Askews and Holts Library Services
-- ASKH
-- AH36559613
938 ## -
-- Coutts Information Services
-- COUT
-- 18019345
938 ## -
-- EBL - Ebook Library
-- EBLB
-- EBL3378782
938 ## -
-- ebrary
-- EBRY
-- ebr10478232
938 ## -
-- EBSCOhost
-- EBSC
-- 372484
938 ## -
-- ProQuest MyiLibrary Digital eBook Collection
-- IDEB
-- 313516
938 ## -
-- YBP Library Services
-- YANK
-- 7082344
994 ## -
-- 92
-- INOPJ
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        E-Books EBSCO OPJGU Sonepat- Campus OPJGU Sonepat- Campus 13/07/2022   13/07/2022 13/07/2022 Electronic-Books

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Hosted, Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library